AstraZeneca Plc (LON: AZN) is in focus this morning following reports that its chief executive – Pascal Soriot is considering ...

It's a threat that will send a shiver down the spine of Downing Street and shake the City of London to its core..

The government must urgently abolish stamp duty on shares and abolish new cash ISAs to prevent the London Stock Exchange ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...

(Reuters) -AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

Cambridge UK Pharma giant AstraZeneca is proving a variation on the proverbial enigma as it ponders the most appreciative ...

AstraZeneca, a United Kingdom-based biopharmaceutical giant, will add 10 to 15 new projects to the company's research and development pipeline in China each year, reflecting its increased ...

AstraZeneca is withdrawing its coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. Skip to main content. You have permission ...

It has not been used in the United Kingdom for some time. “As multiple, variant Covid-19 vaccines have … been developed, there is a surplus of available updated vaccines.